APO RESEARCH · REPORT
Fibrinogen Concentrate
The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc.
Product & engineering
Understand the product.
The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc.
Selected research
Industry Research
Fibrinogen Concentrate Industry Research Report 2026
Market perspective
The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc.
The major producers in the industry are CSL Behring, LFB Group and Shanghai RAAS Blood Products, whose revenue ratios in 2019 are 52.52%, 20.36% and 10.02% respectively.
Report Scope
Read the full market overview
This report quantifies the global Fibrinogen Concentrate market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fibrinogen Concentrate Market by Company
CSL Behring
LFB
Shanghai RAAS
Boya
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Greencross
Shanghai XinXing Medical
Octapharma
Fibrinogen Concentrate Segment by Type
Human Fibrinogen Concentrate
Others
Fibrinogen Concentrate Segment by Application
Surgical Procedures
Congenital Fibrinogen Deficiency
Others
Fibrinogen Concentrate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fibrinogen Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fibrinogen Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fibrinogen Concentrate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fibrinogen Concentrate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fibrinogen Concentrate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fibrinogen Concentrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Human Fibrinogen Concentrate
- Others
Applications
- Surgical Procedures
- Congenital Fibrinogen Deficiency
- Others
Companies covered
- CSL Behring
- LFB
- Shanghai RAAS
- Boya
- Hualan Biological Engineering
- Harbin Pacific Biopharmaceutical
- Greencross
- Shanghai XinXing Medical
- Octapharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fibrinogen Concentrate Market Size (2021-2032)
- 2.2.2 Global Fibrinogen Concentrate Sales (2021-2032)
- 2.2.3 Global Fibrinogen Concentrate Market Average Price (2021-2032)
- 2.3 Fibrinogen Concentrate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Human Fibrinogen Concentrate
- 2.3.3 Others
- 2.4 Fibrinogen Concentrate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Surgical Procedures
- 2.4.3 Congenital Fibrinogen Deficiency
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fibrinogen Concentrate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fibrinogen Concentrate Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Fibrinogen Concentrate Revenue of Manufacturers (2021-2026)
- 3.4 Global Fibrinogen Concentrate Average Price by Manufacturers (2021-2026)
- 3.5 Global Fibrinogen Concentrate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fibrinogen Concentrate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fibrinogen Concentrate, Product Type & Application
- 3.8 Global Manufacturers of Fibrinogen Concentrate, Established Date
- 3.9 Global Fibrinogen Concentrate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 CSL Behring
- 4.1.1 CSL Behring Company Information
- 4.1.2 CSL Behring Business Overview
- 4.1.3 CSL Behring Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 CSL Behring Fibrinogen Concentrate Product Portfolio
- 4.1.5 CSL Behring Recent Developments
- 4.2 LFB
- 4.2.1 LFB Company Information
- 4.2.2 LFB Business Overview
- 4.2.3 LFB Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 LFB Fibrinogen Concentrate Product Portfolio
- 4.2.5 LFB Recent Developments
- 4.3 Shanghai RAAS
- 4.3.1 Shanghai RAAS Company Information
- 4.3.2 Shanghai RAAS Business Overview
- 4.3.3 Shanghai RAAS Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanghai RAAS Fibrinogen Concentrate Product Portfolio
- 4.3.5 Shanghai RAAS Recent Developments
- 4.4 Boya
- 4.4.1 Boya Company Information
- 4.4.2 Boya Business Overview
- 4.4.3 Boya Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Boya Fibrinogen Concentrate Product Portfolio
- 4.4.5 Boya Recent Developments
- 4.5 Hualan Biological Engineering
- 4.5.1 Hualan Biological Engineering Company Information
- 4.5.2 Hualan Biological Engineering Business Overview
- 4.5.3 Hualan Biological Engineering Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hualan Biological Engineering Fibrinogen Concentrate Product Portfolio
- 4.5.5 Hualan Biological Engineering Recent Developments
- 4.6 Harbin Pacific Biopharmaceutical
- 4.6.1 Harbin Pacific Biopharmaceutical Company Information
- 4.6.2 Harbin Pacific Biopharmaceutical Business Overview
- 4.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Harbin Pacific Biopharmaceutical Fibrinogen Concentrate Product Portfolio
- 4.6.5 Harbin Pacific Biopharmaceutical Recent Developments
- 4.7 Greencross
- 4.7.1 Greencross Company Information
- 4.7.2 Greencross Business Overview
- 4.7.3 Greencross Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Greencross Fibrinogen Concentrate Product Portfolio
- 4.7.5 Greencross Recent Developments
- 4.8 Shanghai XinXing Medical
- 4.8.1 Shanghai XinXing Medical Company Information
- 4.8.2 Shanghai XinXing Medical Business Overview
- 4.8.3 Shanghai XinXing Medical Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shanghai XinXing Medical Fibrinogen Concentrate Product Portfolio
- 4.8.5 Shanghai XinXing Medical Recent Developments
- 4.9 Octapharma
- 4.9.1 Octapharma Company Information
- 4.9.2 Octapharma Business Overview
- 4.9.3 Octapharma Fibrinogen Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Octapharma Fibrinogen Concentrate Product Portfolio
- 4.9.5 Octapharma Recent Developments
5 Global Fibrinogen Concentrate Market Scenario by Region
- 5.1 Global Fibrinogen Concentrate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fibrinogen Concentrate Sales by Region: 2021-2032
- 5.2.1 Global Fibrinogen Concentrate Sales by Region: 2021-2026
- 5.2.2 Global Fibrinogen Concentrate Sales by Region: 2027-2032
- 5.3 Global Fibrinogen Concentrate Revenue by Region: 2021-2032
- 5.3.1 Global Fibrinogen Concentrate Revenue by Region: 2021-2026
- 5.3.2 Global Fibrinogen Concentrate Revenue by Region: 2027-2032
- 5.4 North America Fibrinogen Concentrate Market Facts & Figures by Country
- 5.4.1 North America Fibrinogen Concentrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fibrinogen Concentrate Sales by Country (2021-2032)
- 5.4.3 North America Fibrinogen Concentrate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Fibrinogen Concentrate Market Facts & Figures by Country
- 5.5.1 Europe Fibrinogen Concentrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fibrinogen Concentrate Sales by Country (2021-2032)
- 5.5.3 Europe Fibrinogen Concentrate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Fibrinogen Concentrate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fibrinogen Concentrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fibrinogen Concentrate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fibrinogen Concentrate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fibrinogen Concentrate Market Facts & Figures by Country
- 5.7.1 South America Fibrinogen Concentrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fibrinogen Concentrate Sales by Country (2021-2032)
- 5.7.3 South America Fibrinogen Concentrate Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Fibrinogen Concentrate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fibrinogen Concentrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fibrinogen Concentrate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fibrinogen Concentrate Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Fibrinogen Concentrate Sales by Type (2021-2032)
- 6.1.1 Global Fibrinogen Concentrate Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Fibrinogen Concentrate Sales Market Share by Type (2021-2032)
- 6.2 Global Fibrinogen Concentrate Revenue by Type (2021-2032)
- 6.2.1 Global Fibrinogen Concentrate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fibrinogen Concentrate Revenue Market Share by Type (2021-2032)
- 6.3 Global Fibrinogen Concentrate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fibrinogen Concentrate Sales by Application (2021-2032)
- 7.1.1 Global Fibrinogen Concentrate Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Fibrinogen Concentrate Sales Market Share by Application (2021-2032)
- 7.2 Global Fibrinogen Concentrate Revenue by Application (2021-2032)
- 7.2.1 Global Fibrinogen Concentrate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fibrinogen Concentrate Revenue Market Share by Application (2021-2032)
- 7.3 Global Fibrinogen Concentrate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fibrinogen Concentrate Value Chain Analysis
- 8.1.1 Fibrinogen Concentrate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fibrinogen Concentrate Production Mode & Process
- 8.2 Fibrinogen Concentrate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fibrinogen Concentrate Distributors
- 8.2.3 Fibrinogen Concentrate Customers
9 Global Fibrinogen Concentrate Analyzing Market Dynamics
- 9.1 Fibrinogen Concentrate Industry Trends
- 9.2 Fibrinogen Concentrate Industry Drivers
- 9.3 Fibrinogen Concentrate Industry Opportunities and Challenges
- 9.4 Fibrinogen Concentrate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst